Hypnotherapy in Treating Chronic Pain in Cancer Survivors
| Status: | Recruiting |
|---|---|
| Conditions: | Anxiety, Anxiety, Cancer, Cancer, Chronic Pain, Chronic Pain, Depression, Insomnia Sleep Studies |
| Therapuetic Areas: | Musculoskeletal, Oncology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/22/2016 |
| Start Date: | January 2016 |
Hypnosis for Pain Management With Cancer Survivors
This randomized pilot clinical trial studies hypnotherapy in treating chronic pain in cancer
survivors. Hypnotherapy is a state of concentration and focused attention which can provide
more control over the experience of acute and chronic pain and its impact and may provide
comfort, maximize function, and improve quality of life in cancer survivors.
survivors. Hypnotherapy is a state of concentration and focused attention which can provide
more control over the experience of acute and chronic pain and its impact and may provide
comfort, maximize function, and improve quality of life in cancer survivors.
PRIMARY OBJECTIVES:
I. To test the feasibility (recruitment, attrition, adherence, logistical issues) of
delivering the hypnosis (hypnotherapy) intervention to cancer survivors with chronic pain.
II. To evaluate the acceptability of the hypnosis intervention among cancer survivors with
chronic pain.
III. To explore preliminary efficacy (estimate effect size) of hypnosis in relieving pain
and improving associated anxiety and functional performance at 4 weeks and 8 weeks compared
to a wait-list control.
OUTLINE: Participants are randomized to 1 of 2 groups.
IMMEDIATE INTERVENTION GROUP: Participants undergo hypnotherapy session over 20-30 minutes
using a standardized script for pain reduction that contains post-hypnotic suggestions for
permanence of hypnotherapy benefits. The hypnotherapy session is recorded and the
participant listens to the recording daily for 4 weeks.
WAIT-LIST CONTROL GROUP: At week 5, participants undergo hypnotherapy session over 20-30
minutes using a standardized script for pain reduction that contains post-hypnotic
suggestions for permanence of hypnotherapy benefits. The hypnotherapy session is recorded
and the participant listens to the recording daily for 4 weeks.
I. To test the feasibility (recruitment, attrition, adherence, logistical issues) of
delivering the hypnosis (hypnotherapy) intervention to cancer survivors with chronic pain.
II. To evaluate the acceptability of the hypnosis intervention among cancer survivors with
chronic pain.
III. To explore preliminary efficacy (estimate effect size) of hypnosis in relieving pain
and improving associated anxiety and functional performance at 4 weeks and 8 weeks compared
to a wait-list control.
OUTLINE: Participants are randomized to 1 of 2 groups.
IMMEDIATE INTERVENTION GROUP: Participants undergo hypnotherapy session over 20-30 minutes
using a standardized script for pain reduction that contains post-hypnotic suggestions for
permanence of hypnotherapy benefits. The hypnotherapy session is recorded and the
participant listens to the recording daily for 4 weeks.
WAIT-LIST CONTROL GROUP: At week 5, participants undergo hypnotherapy session over 20-30
minutes using a standardized script for pain reduction that contains post-hypnotic
suggestions for permanence of hypnotherapy benefits. The hypnotherapy session is recorded
and the participant listens to the recording daily for 4 weeks.
Inclusion Criteria:
- Self-report of moderate or higher pain on average during the last week (> 3 on a 0-10
pain intensity numeric scale)
- Completed active cancer treatment other than maintenance therapy >= 3 months ago
- Functional fluency in English
- Mentally and physically able to participate and complete surveys over the phone
Exclusion Criteria:
- Chronic pain is not cancer-related
We found this trial at
1
site
Seattle, Washington 98109
Principal Investigator: Kathleen Shannon Dorcy
Phone: 206-288-6586
Click here to add this to my saved trials
